CURE Media Group

A brief discussion on the importance of enrolling in clinical trials and when that may be an option in non-small cell lung cancer.

An in-depth explanation of biomarkers in non-small cell lung cancer, particularly how they can affect the disease and treatment options.

Allison Collins reflects on the genetic testing she underwent after receiving a non-small cell lung cancer diagnosis and describes the treatment options presented to her at that time.

View the full CURE® Educated Patient® Multiple Myeloma Summit in Partnership with Sylvester Comprehensive Cancer Center, University of Miami on demand.

The second annual awards program will honor three heroes for their contributions to the lung cancer community.

Dr. Vamsidhar Velcheti provides an expert’s insight on the testing and staging that must be performed during a diagnosis of non-small cell lung cancer.

Drs. Charu Aggarwal and Hossein Borghaei comment on the importance of having predictive and prognostic biomarkers in non-small cell lung cancer and highlight their approaches to testing patients prior to initiating therapy.

Considerations for the emotional impact of a lung cancer diagnosis and how patients can be supported during their treatment journey.

Approaches that can help lung oncologists discuss symptoms and risk factors of non-small cell lung cancer with patients and their loved ones.

Allison Collins describes her diagnosis with KRAS-positive non-small cell lung cancer and the symptoms that led her to seek medical attention.

Ms. Addario, lung cancer survivor, encourages patients with non-small cell lung cancer to use all the resources and tools that are available to them.

Challenges surrounding the screening of high-risk patients for lung cancer in the community.

Ms. Addario shares the promising hope for patients with lung cancer and describes the steps in the process of biomarker testing for patients with lung cancer.

Advances in non-small cell lung cancer that have helped lung oncologists make more informed treatment decisions with patients.

Treating patients with lung cancer by identifying specific biomarkers to use the correct combination therapy and what it means for a biomarker to be actionable.

Shared insight on the importance of support networks, both medical and personal, in the treatment journey of multiple myeloma.

Taking her own experience with multiple myeloma into account, Marcella shares how she learned to live with the disease by practicing good health and communication habits.

View the full CURE® Educated Patient® Webinar: Treatment and Care for Thyroid Cancer on demand.

A discussion of how patients and physicians can work together to decide on the best individualized treatment option for multiple myeloma.

Kenneth Shain, M.D., Ph.D., and Marcella reflect on how she didn’t tolerate her second line of therapy for multiple myeloma well and moved to a novel treatment regimen thereafter.

Kenneth Shain, M.D., Ph.D., discusses the use of maintenance therapy and observation in multiple myeloma as Marcella shares her own experience with multiple myeloma remission.

Marcella, accompanied by Kenneth Shain, M.D., Ph.D., shares her experience in preparing for autologous stem cell transplant to treat her multiple myeloma.

Kenneth Shain, M.D., Ph.D., and Marcella reflect on the first line of therapy she received for multiple myeloma in light of her response and reaction to certain treatments.

A brief discussion of how Marcella reacted to her diagnosis of multiple myeloma and the importance of support networks for patients.

View the full CURE Educated Patient MPN Summit on demand.

Marcella shares how she met her diagnosis of multiple myeloma as Kenneth Shain, M.D., Ph.D., considers her experience in relation to other patients with multiple myeloma.

View the full CURE® Educated Patient® Webinar: Individualized Treatment for Small Cell Lung Cancer on demand.

View the full CURE® Educated Patient® Webinar: Stomach Cancer 101 Series: Part II - Treatment on demand.

Since 2013, the MPN Heroes® program has honored people and organizations that have dedicated themselves to improving the lives of those with myeloproliferative neoplasms (MPN).

The awards program will honor individuals who have made a significant difference in the lives of those affected by metastatic breast cancer.